Healthcare Services

Cholestatic Pruritus Market: Trends and Growth Potential

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Cholestatic Pruritus Market Grow Between 2026 And 2030?

The cholestatic pruritus market has experienced considerable growth in recent years. It is projected to expand from $20.22 billion in 2025 to $21.3 billion by 2026, at a compound annual growth rate (CAGR) of 5.3%. Historically, this growth has been driven by factors such as the increasing prevalence of chronic liver diseases, limited effectiveness of traditional antihistamines, growth of hepatology specialty care, rising diagnosis of cholestatic disorders, and expansion of supportive care treatments.

The cholestatic pruritus market is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $25.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.1%. Factors contributing to this projected growth include the rising approval of innovative therapies, an elevated emphasis on enhancing patients’ quality of life, the broadened availability of targeted medications for liver diseases, increasing financial commitments to rare disease investigations, and a greater uptake of individualized treatment approaches. Key developments expected during the forecast timeframe encompass the expanding creation of specific anti-pruritic treatments, an increasing concentration on managing particular symptoms, the wider application of oral bile acid modulators, extended research efforts in managing liver conditions, and more sophisticated patient-centric care models.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cholestatic-pruritus-global-market-report

Which Key Drivers Are Affecting The Cholestatic Pruritus Market Development?

The escalating incidence of liver diseases is projected to stimulate the expansion of the cholestatic pruritus market in the coming years. Liver diseases constitute a wide array of conditions that compromise liver function, encompassing infections, autoimmune disorders, genetic illnesses, and damage from toxins, which can lead to inflammation, scarring, or liver failure. The rising occurrence of liver diseases is attributed to increasing obesity rates, diabetes, alcohol consumption, viral hepatitis infections, and exposure to toxins and environmental factors. Cholestatic pruritus assists in the diagnosis and treatment of liver diseases by serving as a critical indicator of compromised bile flow, often prompting additional diagnostic work and management of underlying hepatic conditions. For instance, in 2023, according to the Office for Health Improvement and Disparities (OHID), a UK-Based government agency, England recorded 85,665 hospital admissions for liver disease during the financial year ending in 2023. Consequently, the increasing prevalence of liver diseases will drive the growth of the cholestatic pruritus market.

What Are The Key Segment Divisions In The Cholestatic Pruritus Market Segment Structure?

The cholestatic pruritus market covered in this report is segmented –

1) By Disease Type: Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Intrahepatic Cholestasis Of Pregnancy (ICP), Other Disease Types

2) By Treatment Type: Medications, Phototherapy, Other Treatment Types

3) By Route Of Administration: Oral, Topical, Injectable

4) By End-User: Hospitals, Clinics, Ambulatory Care Centers, Homecare

Subsegments:

1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC, Advanced PBC, PBC With Cirrhosis, PBC With Liver Failure

2) By Primary Sclerosing Cholangitis (PSC): Classic PSC, PSC With Ulcerative Colitis, PSC With Bile Duct Strictures

3) By Intrahepatic Cholestasis Of Pregnancy (ICP): Mild ICP, Severe ICP, ICP With Preterm Birth Risk

4) By Other Disease Types: Alcoholic Cholestasis, Drug-Induced Cholestasis, Viral Hepatitis-Induced Cholestasis, Genetic Cholestasis Disorders

What Trends Are Transforming The Cholestatic Pruritus Market?

Key companies operating in the cholestatic pruritus market are concentrating on developing innovative remedies, such as oral solutions, to manage symptoms more effectively, improve patient compliance, and provide targeted relief by addressing the underlying causes of bile salt accumulation and inflammation. An oral solution for the treatment of cholestatic pruritus is a liquid medication designed to reduce bile acid accumulation and alleviate severe itching in patients with cholestasis. For instance, in March 2024, Mirum Pharmaceuticals Inc., a US-based biopharmaceutical company, obtained approval from the U.S. Food and Drug Administration (FDA) for LIVMARLI (maralixibat) oral solution for treating cholestatic pruritus in patients aged five and older with progressive familial intrahepatic cholestasis (PFIC). This once-daily, orally administered ileal bile acid transporter inhibitor possesses a breakthrough therapy designation for PFIC type 2. LIVMARLI is expected to make a significant impact on patients with cholestatic pruritus linked to PFIC, offering a much-needed treatment option for those with the rarest subtypes.

Which Organizations Are Engaged In The Cholestatic Pruritus Market?

Major companies operating in the cholestatic pruritus market are GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Incyte Corporation, Ipsen Pharma, CANbridge Pharmaceuticals Inc., Escient Pharmaceuticals Inc., Mirum Pharmaceuticals Inc., Albireo Pharma Inc., Cara Therapeutics Inc., CymaBay Therapeutics Inc., Gilead Sciences Inc., Zydus Lifesciences, Genfit SA, NGM Biopharmaceuticals Inc., Calliditas Therapeutics AB, Avior Inc, Travere Therapeutics Inc., 89bio, Hepion Pharmaceuticals, Liminal BioSciences, ProQR Therapeutics NV.

Get The Full Cholestatic Pruritus Market Report:

https://www.thebusinessresearchcompany.com/report/cholestatic-pruritus-global-market-report

Which Region Accounts For The Largest Portion Of The Cholestatic Pruritus Market?

North America was the largest region in the cholestatic pruritus market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cholestatic pruritus market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cholestatic Pruritus Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cholestatic-pruritus-global-market-report

Browse Through More Reports Similar to the Global Cholestatic Pruritus Market 2026, By The Business Research Company

Hidradenitis Suppurativa Market Report 2026

https://www.thebusinessresearchcompany.com/report/hidradenitis-suppurativa-global-market-report

Pruritus Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

Pompe Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/pompe-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795